Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Mesoblast
(NASDAQ:MESO)
Intraday
$6.12
0.12
[2.00%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$6.12
0.12
[2.00%]
Last update: 2:39PM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Mesoblast Stock (NASDAQ:MESO)
Mesoblast Stock (NASDAQ: MESO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 23, 2024
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
1 day ago
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
-
1 day ago
Wednesday, April 17, 2024
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Apr 17, 2024, 10:55AM
Monday, April 08, 2024
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Apr 8, 2024, 1:10PM
Model N, Ducommun, Perpetua Resources And Other Big Stocks Moving Higher On Monday
Avi Kapoor
-
Apr 8, 2024, 10:17AM
Wednesday, April 03, 2024
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Apr 3, 2024, 1:56PM
Why Cal-Maine Foods Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Apr 3, 2024, 8:10AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Apr 3, 2024, 8:09AM
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
-
Apr 3, 2024, 5:36AM
Monday, April 01, 2024
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Apr 1, 2024, 2:31PM
Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday
Avi Kapoor
-
Apr 1, 2024, 1:02PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Apr 1, 2024, 12:31PM
Friday, March 29, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Mar 29, 2024, 12:30PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 29, 2024, 8:06AM
Thursday, March 28, 2024
Mesoblast shares are trading higher after the FDA earlier in the week informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L.
Benzinga Newsdesk
-
Mar 28, 2024, 3:42PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Mar 28, 2024, 12:31PM
Mesoblast Shares Resume Trade
Benzinga Newsdesk
-
Mar 28, 2024, 9:41AM
Mesoblast Shares Halted On Circuit Breaker To The Downside
Benzinga Newsdesk
-
Mar 28, 2024, 9:38AM
Top 5 Health Care Stocks That May Plunge In March
Avi Kapoor
-
Mar 28, 2024, 8:30AM
Wednesday, March 27, 2024
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Mar 27, 2024, 1:06PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Mar 27, 2024, 12:31PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Mar 27, 2024, 9:05AM
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 27, 2024, 8:14AM
GameStop Posts Downbeat Results, Joins Direct Digital, Forge Global And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
-
Mar 27, 2024, 5:39AM
Tuesday, March 26, 2024
Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates
Avi Kapoor
-
Mar 26, 2024, 3:08PM
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Mar 26, 2024, 1:45PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Mar 26, 2024, 1:31PM
After Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell Transplant
Vandana Singh
-
Mar 26, 2024, 12:47PM
Dow Gains 100 Points; McCormick Posts Upbeat Results
Avi Kapoor
-
Mar 26, 2024, 12:08PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Mar 26, 2024, 9:05AM
Market-Moving News for March 26th
Benzinga Newsdesk
-
Mar 26, 2024, 8:26AM
Mesoblast shares are trading higher after the FDA informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L for treatment of pediatric patients with steroid-refractory acute graft versus host disease.
Benzinga Newsdesk
-
Mar 26, 2024, 8:14AM
Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 26, 2024, 8:00AM
Reported Earlier, Mesoblast Notified By The U.S. FDA That Available Clinical Data From Phase 3 Trial Appear Sufficient To Support BLA Submission For Remestemcel-L In Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
Benzinga Newsdesk
-
Mar 26, 2024, 1:48AM
Friday, March 22, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Mar 22, 2024, 5:33PM
Monday, March 11, 2024
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Mar 11, 2024, 1:41PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Mar 11, 2024, 1:31PM
Mesoblast shares are trading higher after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.
Benzinga Newsdesk
-
Mar 11, 2024, 9:50AM
Reported Sunday March 10, 2024, U.S. FDA Supports Accelerated Approval Pathway for Rexlemestrocel-L In End-Stage Heart Failure Patients With A Left Ventricular Assist Device
Benzinga Newsdesk
-
Mar 11, 2024, 9:48AM
Why Is Cell Therapy Focused-Mesoblast Stock Trading Higher On Monday?
Vandana Singh
-
Mar 11, 2024, 9:24AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Mar 11, 2024, 9:05AM
Market-Moving News for March 11th
Benzinga Newsdesk
-
Mar 11, 2024, 8:40AM
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 11, 2024, 8:08AM
Sunday, March 10, 2024
Mesoblast Announced FDA Supports Accelerated Approval Pathway For Rexlemestrocel-l In End-stage Heart Failure Patients With A Left Ventricular Assist Device
Charles Gross
-
Mar 10, 2024, 7:37PM
Wednesday, February 28, 2024
Mesoblast Reports H1 FY2024 Loss After Tax Of $(32.5)M, A 21% Reduction From $(41.4)M Last Year
Benzinga Newsdesk
-
Feb 28, 2024, 6:01PM
Thursday, February 15, 2024
The United States Food And Drug Administration Grants Orphan-Drug Status To Mesoblast's Revascor For Children With Congenital Heart Disease
Benzinga Newsdesk
-
Feb 15, 2024, 2:54AM
Tuesday, February 13, 2024
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting
Faith Ashmore
-
Sponsored
Wednesday, January 31, 2024
Mesoblast Announces Advancements In Phase 3 Trials iIQ2 Activity Report, Registers $1.5M in Royalty Revenue From TEMCELL® HS Inj.5 Sales In Japan
Benzinga Newsdesk
-
Jan 31, 2024, 2:10AM
Friday, January 26, 2024
Top 4 Health Care Stocks That May Explode This Month
Avi Kapoor
-
Jan 26, 2024, 7:03AM
Tuesday, January 23, 2024
Why 3M Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
Jan 23, 2024, 2:37PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch